However, 2026 has introduced new ways to save, making these treatments more accessible through direct-to-consumer programs and government bridge initiatives
This helps ensure a smooth switch without affecting your blood sugar control
First, its essential to understand that semaglutide is a GLP-1 receptor agonist
These numbers aren't an indictment of the drugs so much as a signal about how we develop and target them: pain is mechanistically diverse, and treating heterogeneous populations with one-size-fits-all therapies dilutes the responders
Current Regulatory Status in the UK and Globally As of mid-2025, retatrutide has no marketing authorisation in the UK, EU, or US
Mounjaro Approved For Both Diabetes And Weight Loss Treatments The dual effectiveness of Mounjaro in treating type 2 diabetes and promoting weight loss has made it a notable option in modern medicine